CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Microbot Medical Inc. - MBOT CFD

1.03
1.9%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.05
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.02629 %
Charges from full value of position ($-5.00)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.02629%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004068 %
Charges from full value of position ($0.77)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004068%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 1.05
Open 1.04
1-Year Change -59.53%
Day's Range 1.03 - 1.05
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jul 18, 2024 1.05 -0.01 -0.94% 1.06 1.07 1.04
Jul 17, 2024 1.04 -0.03 -2.80% 1.07 1.07 1.03
Jul 16, 2024 1.07 -0.01 -0.93% 1.08 1.09 1.07
Jul 15, 2024 1.07 0.02 1.90% 1.05 1.07 1.05
Jul 12, 2024 1.05 0.01 0.96% 1.04 1.07 1.04
Jul 11, 2024 1.04 -0.02 -1.89% 1.06 1.07 1.04
Jul 10, 2024 1.05 0.00 0.00% 1.05 1.06 1.03
Jul 9, 2024 1.05 0.00 0.00% 1.05 1.05 1.04
Jul 8, 2024 1.05 -0.01 -0.94% 1.06 1.07 1.03
Jul 5, 2024 1.04 0.03 2.97% 1.01 1.04 1.01
Jul 3, 2024 1.00 0.03 3.09% 0.97 1.08 0.97
Jul 2, 2024 0.97 0.01 1.04% 0.96 0.97 0.94
Jul 1, 2024 0.98 0.00 0.00% 0.98 0.99 0.96
Jun 28, 2024 1.00 -0.01 -0.99% 1.01 1.01 1.00
Jun 27, 2024 1.01 0.04 4.12% 0.97 1.02 0.97
Jun 26, 2024 0.97 -0.03 -3.00% 1.00 1.00 0.97
Jun 25, 2024 1.01 -0.01 -0.98% 1.02 1.02 1.00
Jun 24, 2024 1.02 0.02 2.00% 1.00 1.02 0.99
Jun 21, 2024 1.01 0.02 2.02% 0.99 1.01 0.99
Jun 20, 2024 1.01 0.03 3.06% 0.98 1.01 0.98

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Microbot Medical Inc. Company profile

About Microbot Medical Inc

Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms are comprised of ViRob, TipCAT and Liberty, including certain CardioSert assets. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH). Utilizing the Liberty and CardioSert platforms, it is developing disposable robot for various endovascular interventional procedures. ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. TipCAT is a disposable self-propelled locomotive device, designed to advance in tubular anatomies. Liberty is a disposable robotic system, designed to move guidewires and over-the-wire devices, such as microcatheters within the body’s vasculature.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Microbot Medical Inc revenues was not reported. Net loss increased 14% to $7.5M. Higher net loss reflects Research and development increase of 63% to $3.9M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.92 to -$1.05.

Equity composition

Common $.1 Par, 07/11, 250M auth., 13,784,019 issd,. Insiders control approx. 8.68%. IPO 3/92, 2.25M shares @ $11.00 by Robertson, Stephens & Co. PO 9/95, 2.3M shares @ $9.375. 10/93, *5/00, Name changed from Cytotherapeutics, Inc. PO: 11/08, 13.8M shares. 07/11, 1-for-10 reverse stock split. 05/16 1-for-12 reverse stock split.

Industry: Biotechnology & Medical Research (NEC)

25 Recreation Park Dr Suite 108
HINGHAM
MASSACHUSETTS 02043
US

People also watch

Gold

2,401.36 Price
-1.830% 1D Chg, %
Long position overnight fee -0.0198%
Short position overnight fee 0.0116%
Overnight fee time 21:00 (UTC)
Spread 1.20

US100

19,526.60 Price
-1.140% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 21:00 (UTC)
Spread 7.0

XRP/USD

0.58 Price
+2.020% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,497.84 Price
+2.370% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Still looking for a broker you can trust?

Join the 630,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading